Related references
Note: Only part of the references are listed.KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model
Analisa DiFeo et al.
CANCER RESEARCH (2009)
The role of KLF6 and its splice variants in cancer therapy
Analisa DiFeo et al.
DRUG RESISTANCE UPDATES (2009)
Functional role of the KLF6 tumour suppressor gene in gastric cancer
Jaya Sangodkar et al.
EUROPEAN JOURNAL OF CANCER (2009)
Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells
Kexing Fan et al.
ARTHRITIS AND RHEUMATISM (2008)
Transforming growth factor β induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells
Jing Wang et al.
CANCER RESEARCH (2008)
A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response
Analisa Difeo et al.
CANCER RESEARCH (2008)
Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer
Mark Hartel et al.
EUROPEAN JOURNAL OF CANCER (2008)
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis
Goutham Narla et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
BH3 mimetics to improve cancer therapy; mechanisms and examples
Lin Zhang et al.
DRUG RESISTANCE UPDATES (2007)
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma
Miriam S. Teixeira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma
Olga Camacho-Vanegas et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation
Sigal Kremer-Tal et al.
JOURNAL OF HEPATOLOGY (2007)
Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma
Jaehwi Song et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination
Analisa DiFeo et al.
CLINICAL CANCER RESEARCH (2006)
Prospects of RNA interference therapy for cancer
SI Pai et al.
GENE THERAPY (2006)
Genetic alterations of the KLF6 gene in colorectal cancers
Yong Gu Cho et al.
APMIS (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells
SJ Jeong et al.
ONCOGENE (2005)
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread
G Narla et al.
CANCER RESEARCH (2005)
Genetic alterations of the KLF6 gene in gastric cancer
YG Cho et al.
ONCOGENE (2005)
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk
G Narla et al.
CANCER RESEARCH (2005)
Inhibition of respiratory viruses by nasally administered siRNA
V Bitko et al.
NATURE MEDICINE (2005)
Kruppel-Like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer
HL Reeves et al.
GASTROENTEROLOGY (2004)
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1
S Benzeno et al.
CANCER RESEARCH (2004)
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma
S Kremer-Tal et al.
HEPATOLOGY (2004)
Kruppel-Like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells
G Ito et al.
CANCER RESEARCH (2004)
A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function
DA Slavin et al.
ONCOGENE (2004)
KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas
YM Jeng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
CS Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Death and anti-death: Tumour resistance to apoptosis
FH Igney et al.
NATURE REVIEWS CANCER (2002)
Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector
SF Jia et al.
CANCER GENE THERAPY (2002)
KLF6, a candidate tumor suppressor gene mutated in prostate cancer
G Narla et al.
SCIENCE (2001)
Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
AR Black et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
T Bartke et al.
ONCOGENE (2001)
Current status and future perspectives in gastric cancer management
DH Roukos
CANCER TREATMENT REVIEWS (2000)
Share Paper
